Manjima Dhar
Overview
Explore the profile of Manjima Dhar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
290
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fast E, Dhar M, Chen B
bioRxiv
. 2023 Sep;
PMID: 37745475
T-cell receptors (TCRs) are involved in most human diseases, but linking their sequences with their targets remains an unsolved grand challenge in the field. In this study, we present TAPIR...
2.
Lin J, Kim D, Tse H, Tseng P, Peng L, Dhar M, et al.
Microsyst Nanoeng
. 2019 May;
3:17013.
PMID: 31057860
In this report, we present multiparameter deformability cytometry (m-DC), in which we explore a large set of parameters describing the physical phenotypes of pluripotent cells and their derivatives. m-DC utilizes...
3.
Murray C, Miwa H, Dhar M, Park D, Pao E, Martinez J, et al.
Lab Chip
. 2018 Nov;
18(23):3703.
PMID: 30420988
Correction for 'Unsupervised capture and profiling of rare immune cells using multi-directional magnetic ratcheting' by Coleman Murray et al., Lab Chip, 2018, 18, 2396-2409.
4.
Dhar M, Lam J, Walser T, Dubinett S, Rettig M, Di Carlo D
Proc Natl Acad Sci U S A
. 2018 Sep;
115(40):9986-9991.
PMID: 30224472
Tumor cells are hypothesized to use proteolytic enzymes to facilitate invasion. Whether circulating tumor cells (CTCs) secrete these enzymes to aid metastasis is unknown. A quantitative and high-throughput approach to...
5.
Murray C, Miwa H, Dhar M, Park D, Pao E, Martinez J, et al.
Lab Chip
. 2018 Jul;
18(16):2396-2409.
PMID: 30039125
Immunotherapies (IT) require induction, expansion, and maintenance of specific changes to a patient's immune cell repertoire which yield a therapeutic benefit. Recently, mechanistic understanding of these changes at the cellular...
6.
Dhar M, Wong J, Che J, Matsumoto M, Grogan T, Elashoff D, et al.
Sci Rep
. 2018 Feb;
8(1):2592.
PMID: 29416054
Metastatic non-small cell lung cancer (NSCLC) is a highly fatal and immunogenic malignancy. Although the immune system is known to recognize these tumor cells, one mechanism by which NSCLC can...
7.
Dhar M, Pao E, Renier C, Go D, Che J, Montoya R, et al.
Sci Rep
. 2016 Oct;
6:35474.
PMID: 27739521
Circulating tumor cells (CTCs) have a great potential as indicators of metastatic disease that may help physicians improve cancer prognostication, treatment and patient outcomes. Heterogeneous marker expression as well as...
8.
Che J, Yu V, Dhar M, Renier C, Matsumoto M, Heirich K, et al.
Oncotarget
. 2016 Feb;
7(11):12748-60.
PMID: 26863573
Circulating tumor cells (CTCs) are emerging as rare but clinically significant non-invasive cellular biomarkers for cancer patient prognosis, treatment selection, and treatment monitoring. Current CTC isolation approaches, such as immunoaffinity,...
9.
Dhar M, Wong J, Karimi A, Che J, Renier C, Matsumoto M, et al.
Biomicrofluidics
. 2015 Dec;
9(6):064116.
PMID: 26697126
Circulating tumor cells (CTCs) are important biomarkers for monitoring tumor dynamics and efficacy of cancer therapy. Several technologies have been demonstrated to isolate CTCs with high efficiency but achieve a...
10.
Dhar M, Khojah R, Tay A, Di Carlo D
Lab Chip
. 2015 Sep;
15(21):4109-13.
PMID: 26405849
Individual cells are the fundamental unit of life with diverse functions from metabolism to motility. In multicellular organisms, a single genome can give rise to tremendous variability across tissues at...